Zhejiang Realsun Chemical Co.,Ltd. (SHE:301212)
China · Delayed Price · Currency is CNY 29.02
0.00 (0.00%)
At close: May 6, 2026
Zhejiang Realsun Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 703.04 | 693.39 | 632.46 | 662.02 | 1,041 | 831.01 |
Other Revenue | - | - | - | - | - | 2.01 |
| 703.04 | 693.39 | 632.46 | 662.02 | 1,041 | 833.01 | |
Revenue Growth (YoY) | 4.22% | 9.63% | -4.46% | -36.41% | 24.98% | 22.55% |
Cost of Revenue | 614.57 | 612.81 | 570.63 | 540.47 | 789.66 | 653.47 |
Gross Profit | 88.46 | 80.58 | 61.83 | 121.54 | 251.47 | 179.54 |
Selling, General & Admin | 47.56 | 42.22 | 35.88 | 41.6 | 40.98 | 36.31 |
Research & Development | 27.42 | 25.06 | 20.39 | 25.57 | 32.94 | 26.24 |
Other Operating Expenses | 0.02 | -0.38 | 1.34 | 1.75 | 4.51 | 3.05 |
Operating Expenses | 75 | 66.91 | 60.18 | 65.07 | 78.47 | 66.23 |
Operating Income | 13.46 | 13.67 | 1.64 | 56.47 | 173 | 113.31 |
Interest Expense | - | - | -0.08 | -0.22 | -1.94 | -1.81 |
Interest & Investment Income | 1.34 | 1.35 | 12.78 | 19.86 | 15.87 | 0.24 |
Currency Exchange Gain (Loss) | - | - | 2.75 | 3.57 | 32.17 | -5.35 |
Other Non Operating Income (Expenses) | -1.45 | 2.87 | -0.31 | -0.23 | -0.6 | -0.59 |
EBT Excluding Unusual Items | 13.36 | 17.9 | 16.79 | 79.45 | 218.5 | 105.8 |
Gain (Loss) on Sale of Investments | -1.07 | -0.64 | 0.04 | 0.28 | -1.55 | -0.37 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | - | -1.05 | 0.04 | 0.26 |
Asset Writedown | -0.44 | 0.05 | -0.17 | -1.86 | -3.83 | -6.27 |
Other Unusual Items | - | - | 0.96 | 5.4 | 5.58 | 6.36 |
Pretax Income | 11.87 | 17.33 | 17.63 | 82.21 | 218.74 | 105.8 |
Income Tax Expense | -0.04 | 0.89 | 2.21 | 10.46 | 27.58 | 12.99 |
Earnings From Continuing Operations | 11.91 | 16.44 | 15.41 | 71.76 | 191.16 | 92.81 |
Minority Interest in Earnings | -3.14 | -2.59 | 1.85 | -0.64 | -8.2 | -4.29 |
Net Income | 8.77 | 13.85 | 17.26 | 71.11 | 182.97 | 88.52 |
Net Income to Common | 8.77 | 13.85 | 17.26 | 71.11 | 182.97 | 88.52 |
Net Income Growth | -57.09% | -19.74% | -75.73% | -61.13% | 106.69% | -9.44% |
Shares Outstanding (Basic) | 104 | 107 | 108 | 108 | 99 | 81 |
Shares Outstanding (Diluted) | 104 | 107 | 108 | 108 | 99 | 81 |
Shares Change (YoY) | -3.01% | -1.21% | 0.11% | 8.95% | 21.78% | 0.54% |
EPS (Basic) | 0.08 | 0.13 | 0.16 | 0.66 | 1.85 | 1.09 |
EPS (Diluted) | 0.08 | 0.13 | 0.16 | 0.66 | 1.85 | 1.09 |
EPS Growth | -55.75% | -18.75% | -75.76% | -64.32% | 69.73% | -9.92% |
Free Cash Flow | -80.45 | -44.37 | -331.06 | -52.68 | -74.42 | 107.08 |
Free Cash Flow Per Share | -0.77 | -0.42 | -3.07 | -0.49 | -0.75 | 1.32 |
Dividend Per Share | - | - | 0.120 | 0.198 | 0.380 | 0.205 |
Dividend Growth | - | - | -39.39% | -47.89% | 85.37% | - |
Gross Margin | 12.58% | 11.62% | 9.78% | 18.36% | 24.15% | 21.55% |
Operating Margin | 1.92% | 1.97% | 0.26% | 8.53% | 16.62% | 13.60% |
Profit Margin | 1.25% | 2.00% | 2.73% | 10.74% | 17.57% | 10.63% |
Free Cash Flow Margin | -11.44% | -6.40% | -52.34% | -7.96% | -7.15% | 12.86% |
EBITDA | 59.03 | 56.99 | 35.97 | 86.51 | 203.77 | 135.14 |
EBITDA Margin | 8.40% | 8.22% | 5.69% | 13.07% | 19.57% | 16.22% |
D&A For EBITDA | 45.57 | 43.32 | 34.32 | 30.04 | 30.77 | 21.83 |
EBIT | 13.46 | 13.67 | 1.64 | 56.47 | 173 | 113.31 |
EBIT Margin | 1.92% | 1.97% | 0.26% | 8.53% | 16.62% | 13.60% |
Effective Tax Rate | - | 5.11% | 12.56% | 12.72% | 12.61% | 12.28% |
Revenue as Reported | - | - | 632.46 | 662.02 | 1,041 | 833.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.